AMOKSIKLAV 457 MG/5 ML
400MG/5ML+57MG/5ML POR PLV SUS 140ML
| SÚKL code | 0099367 |
|---|---|
| Name of the product | AMOKSIKLAV 457 MG/5 ML |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | AMOKSIKLAV 457 MG/5 ML |
| Supplement | 400MG/5ML+57MG/5ML POR PLV SUS 140ML |
| Strenght | 400MG/5ML+57MG/5ML |
| Pharmaceutical form | Powder for oral suspension |
| Package | 140ML |
| Route | Oral use |
| Language of the pack | Czech |
| Wrap type | Bottle |
| Legal status | na lékařský předpis |
| Active substance |
POTASSIUM CLAVULANATE (KALII CLAVULANAS) AMOXICILLIN TRIHYDRATE (AMOXICILLINUM TRIHYDRICUM) |
| ATC group | J01CR02 |
| ATC group name | AMOXICILIN A INHIBITOR BETA-LAKTAMASY |
Marketing authorisation information
| Registration Number | 15/ 387/05-C |
|---|---|
| Type of MA | National |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 31. 10. 2021 |
| MA Holder | Lek Pharmaceuticals d.d., Ljubljana |
| MA Holder country | SLOVINSKO |
| Actual MA holder | Lek Pharmaceuticals d.d., Ljubljana |
| Actual MA holder country | SLOVINSKO |
cz